Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville
February 11, 2019 07:00 ET
|
Recro Pharma, Inc.
Company Continues Long-Term, Strategic Relationship with Key Customer Recro Gainesville to be Exclusive Supplier of Ritalin LA® and Focalin XR® Capsules with “Total Revenue Per Capsule Economics”...
Recro Pharma Amends Athyrium Credit Facility
January 02, 2019 07:00 ET
|
Recro Pharma, Inc.
New Terms Provide for Continued Access to $40 Million in Debt Funding $10 Million of the $40 Million Funded at Closing MALVERN, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc....
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
December 21, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology
December 10, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia
November 14, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma to Participate in Upcoming Investor Conferences
November 08, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018
November 07, 2018 07:00 ET
|
Recro Pharma, Inc.
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused...
Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
October 31, 2018 07:00 ET
|
Recro Pharma, Inc.
Conference Call and Webcast Scheduled for Wednesday, November 7, 2018 at 8:00 a.m. ET MALVERN, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating...
Recro Pharma Announces PDUFA Date for IV Meloxicam
October 08, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Announces Expansion of CDMO Service Capabilities
October 01, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...